PROGRAM CO-CHAIRS
| Robert D. Toto, MD Professor of Internal Medicine and Public Health University of Texas Southwestern Medical Center Dallas, TX |
Matthew Weir, MD Professor and Chief, Division of Nephrology Department of Medicine, University of Maryland School of Medicine Baltimore, MD |
PANELIST
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone Disorders
Detroit, MI
PROGRAM OVERVIEW
This enduring activity focuses on up-to-date management of CKD. Faculty will discuss strategies for earlier CKD diagnosis and provide information on current and emerging therapies. The speakers will also provide clinical practice tools that are illustrated through video cases, and discuss multidisciplinary care strategies for the comprehensive management of CKD.
TARGET AUDIENCE
This educational activity is intended for global primary care providers and nephrologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Determine strategies for the early identification of CKD in patients at risk
- Assess clinical evidence on the safety and efficacy profiles of the various classes of agents used in the management of CKD
- Apply clinical guidelines when formulating management strategies for patients with CKD
- Select strategies for implementing multidisciplinary care for patients with CKD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
EACCME CREDIT DESIGNATION STATEMENT
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at [email protected].
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Robert D. Toto, MD | Has nothing to disclose. |
| Matthew Weir, MD | Discloses that he has received consulting fees from Bayer, Novo Nordisk, CSL Vifor, AstraZeneca, and Boehringer-Ingelheim. |
| Davida F. Kruger, MSN, APN-BC, BC-ADM | Discloses that she has received consultant fees from Novo Nordisk, Lilly, Abbott, Embecta, CeQur Corporation, MannKind Corporation, Insulet, Medtronic, and Sanofi. She is on the speakers bureau for Lilly, Novo Nordisk, Dexcom, CeQur Corporation, Sanofi, and Xeris Biopharma. She does contract research for Abbott, Beta Bionics, Insulet, NovoNordisk, and Tandem. Also reports stock options (Not exercised) with Pendulum. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
- Chris Drury, Medical Director for Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
- Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
- Mike Milano, MD, has received royalties from Wolters Kluwer (Up ToDate author royalties)
- Nicolas Applyrs Jr, D.O., M.S., M.P.H., has nothing to disclose.
- Lauren Bartunek, Program Manager for Med Learning Group, has nothing to disclose.
- Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: March 25, 2024
EXPIRATION DATE: March 25, 2025
Copyright ©2024 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
